Literature DB >> 21572083

Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.

Shanmugam Muruganandan1, Sebastian D Parlee, Jillian L Rourke, Matthew C Ernst, Kerry B Goralski, Christopher J Sinal.   

Abstract

Chemerin is an adipocyte-secreted protein that regulates adipogenesis and the metabolic function of mature adipocytes via activation of chemokine-like receptor 1 (CMKLR1). Herein we report the interaction of peroxisome proliferator-activated receptor γ (PPARγ) and chemerin in the context of adipogenesis. Knockdown of chemerin or CMKLR1 expression or antibody neutralization of secreted chemerin protein arrested adipogenic clonal expansion of bone marrow mesenchymal stem cells (BMSCs) by inducing a loss of G(2)/M cyclins (cyclin A2/B2) but not the G(1)/S cyclin D2. Forced expression of PPARγ in BMSCs did not completely rescue this loss of clonal expansion and adipogenesis following chemerin or CMKLR1 knockdown. However, forced expression and/or activation of PPARγ in BMSCs as well as non-adipogenic cell types such as NIH-3T3 embryonic fibroblasts and MCA38 colon carcinoma cells significantly induced chemerin expression and secretion. Sequence analysis revealed a putative PPARγ response element (PPRE) sequence within the chemerin promoter. This PPRE was able to confer PPARγ responsiveness on a heterologous promoter, and mutation of this sequence abolished activation of the chemerin promoter by PPARγ. Chromatin immunoprecipitation confirmed the direct association of PPARγ with this PPRE. Treatment of mice with rosiglitazone elevated chemerin mRNA levels in adipose tissue and bone marrow coincident with an increase in circulating chemerin levels. Together, these findings support a fundamental role for chemerin/CMKLR1 signaling in clonal expansion during adipocyte differentiation as well as a role for PPARγ in regulating chemerin expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572083      PMCID: PMC3129180          DOI: 10.1074/jbc.M111.220491

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Evolving intricacies and implications of E2F1 regulation.

Authors:  Suneel D Mundle; Gurveen Saberwal
Journal:  FASEB J       Date:  2003-04       Impact factor: 5.191

2.  PPARgamma1 synthesis and adipogenesis in C3H10T1/2 cells depends on S-phase progression, but does not require mitotic clonal expansion.

Authors:  Young C Cho; Colin R Jefcoate
Journal:  J Cell Biochem       Date:  2004-02-01       Impact factor: 4.429

3.  PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein.

Authors:  N Maeda; M Takahashi; T Funahashi; S Kihara; H Nishizawa; K Kishida; H Nagaretani; M Matsuda; R Komuro; N Ouchi; H Kuriyama; K Hotta; T Nakamura; I Shimomura; Y Matsuzawa
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

4.  Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study.

Authors:  Bruce B Duncan; Maria Inês Schmidt; James S Pankow; Heejung Bang; David Couper; Christie M Ballantyne; Ron C Hoogeveen; Gerardo Heiss
Journal:  Diabetes       Date:  2004-09       Impact factor: 9.461

5.  Cyclin D1 repression of peroxisome proliferator-activated receptor gamma expression and transactivation.

Authors:  Chenguang Wang; Nagarajan Pattabiraman; Jian Nian Zhou; Maofu Fu; Toshiyuki Sakamaki; Chris Albanese; Zhiping Li; Kongming Wu; James Hulit; Peter Neumeister; Phyllis M Novikoff; Michael Brownlee; Philipp E Scherer; Joan G Jones; Kathleen D Whitney; Lawrence A Donehower; Emily L Harris; Thomas Rohan; David C Johns; Richard G Pestell
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

6.  Characterization of human circulating TIG2 as a ligand for the orphan receptor ChemR23.

Authors:  W Meder; M Wendland; A Busmann; C Kutzleb; N Spodsberg; H John; R Richter; D Schleuder; M Meyer; W G Forssmann
Journal:  FEBS Lett       Date:  2003-12-18       Impact factor: 4.124

7.  Chemerin is a novel adipokine associated with obesity and metabolic syndrome.

Authors:  Kiymet Bozaoglu; Kristy Bolton; Janine McMillan; Paul Zimmet; Jeremy Jowett; Greg Collier; Ken Walder; David Segal
Journal:  Endocrinology       Date:  2007-07-19       Impact factor: 4.736

8.  CCAAT/enhancer-binding protein beta is required for mitotic clonal expansion during adipogenesis.

Authors:  Qi-Qun Tang; Tamara C Otto; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

9.  Mitotic clonal expansion: a synchronous process required for adipogenesis.

Authors:  Qi-Qun Tang; Tamara C Otto; M Daniel Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-26       Impact factor: 11.205

10.  Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids.

Authors:  Valérie Wittamer; Jean-Denis Franssen; Marisa Vulcano; Jean-François Mirjolet; Emmanuel Le Poul; Isabelle Migeotte; Stéphane Brézillon; Richard Tyldesley; Cédric Blanpain; Michel Detheux; Alberto Mantovani; Silvano Sozzani; Gilbert Vassart; Marc Parmentier; David Communi
Journal:  J Exp Med       Date:  2003-10-06       Impact factor: 14.307

View more
  42 in total

1.  Exercise-induced lowering of chemerin is associated with reduced cardiometabolic risk and glucose-stimulated insulin secretion in older adults.

Authors:  S K Malin; S D Navaneethan; A Mulya; H Huang; J P Kirwan
Journal:  J Nutr Health Aging       Date:  2014       Impact factor: 4.075

2.  Smoking during pregnancy increases chemerin expression in neonatal tissue.

Authors:  Leryn J Reynolds; Niraj R Chavan; Logan B DeHoff; Joshua D Preston; Hannah F Maddox; John M O'Brien; David A Armstrong; Carmen J Marsit; Kevin J Pearson
Journal:  Exp Physiol       Date:  2018-11-22       Impact factor: 2.969

3.  The simulated microgravity enhances multipotential differentiation capacity of bone marrow mesenchymal stem cells.

Authors:  Nanding Wang; Huan Wang; Jun Chen; Xiaofeng Zhang; Juan Xie; Zhi Li; Jing Ma; Wen Wang; Zongren Wang
Journal:  Cytotechnology       Date:  2013-04-12       Impact factor: 2.058

4.  Specific differentiation of mesenchymal stem cells by small molecules.

Authors:  Heesang Song; Woochul Chang; Byeong-Wook Song; Ki-Chul Hwang
Journal:  Am J Stem Cells       Date:  2011-08-18

5.  Disruption of the chemokine-like receptor-1 (CMKLR1) gene is associated with reduced adiposity and glucose intolerance.

Authors:  Matthew C Ernst; Ian D Haidl; Luis A Zúñiga; Helen J Dranse; Jillian L Rourke; Brian A Zabel; Eugene C Butcher; Christopher J Sinal
Journal:  Endocrinology       Date:  2011-12-20       Impact factor: 4.736

Review 6.  Chemerin: a potential endocrine link between obesity and type 2 diabetes.

Authors:  Alexandra A Roman; Sebastian D Parlee; Christopher J Sinal
Journal:  Endocrine       Date:  2012-05-19       Impact factor: 3.633

7.  Chemokine-like receptor 1 regulates skeletal muscle cell myogenesis.

Authors:  Mark E Issa; Shanmugam Muruganandan; Matthew C Ernst; Sebastian D Parlee; Brian A Zabel; Eugene C Butcher; Christopher J Sinal; Kerry B Goralski
Journal:  Am J Physiol Cell Physiol       Date:  2012-03-28       Impact factor: 4.249

8.  NOS1AP Functionally Associates with YAP To Regulate Hippo Signaling.

Authors:  Leanne Clattenburg; Michael Wigerius; Jiansong Qi; Jan K Rainey; Jillian L Rourke; Shanmugam Muruganandan; Christopher J Sinal; James P Fawcett
Journal:  Mol Cell Biol       Date:  2015-04-27       Impact factor: 4.272

9.  Chemerin connects fat to arterial contraction.

Authors:  Stephanie W Watts; Anne M Dorrance; Mark E Penfold; Jillian L Rourke; Christopher J Sinal; Bridget Seitz; Timothy J Sullivan; Trevor T Charvat; Janice M Thompson; Robert Burnett; Gregory D Fink
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

10.  Chemokine-like receptor 1 deficiency leads to lower bone mass in male mice.

Authors:  Huashan Zhao; Dewen Yan; Liang Xiang; Chen Huang; Jian Li; Xiangfang Yu; Binbin Huang; Baobei Wang; Jie Chen; Tianxia Xiao; Pei-Gen Ren; Jian V Zhang
Journal:  Cell Mol Life Sci       Date:  2018-10-29       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.